Autopsy report · NCT00953615

Thalidomide for the Treatment of Primary Sclerosing Cholangitis (PSC)

“Lack of enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 years 4 months after it had already started.
• Ran for about 3 years 1 month before it stopped.
• 1 participant enrolled.
• Results were posted on the registry 2 years 9 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Mayo Clinic

Sponsor type

University, hospital or other

Conditions

Primary Sclerosing Cholangitis

Interventions

Thalidomide

Participants

1

Sites

1

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.